Document is current
Any future updates will be listed below
-
Authors
Paskins, Zoe https://orcid.org/0000-0002-7783-2986
Moult, Alice https://orcid.org/0000-0002-9424-5660
Corp, Nadia https://orcid.org/0000-0002-6758-9513
Bastounis, Anastasios https://orcid.org/0000-0001-5861-9373
Davis, Sarah https://orcid.org/0000-0002-6609-4287
Narayanasamy, Melanie Jay https://orcid.org/0000-0003-3483-0777
Griffin, Jill
Gittoes, Neil https://orcid.org/0000-0001-5963-214X
Leonardi-Bee, Jo https://orcid.org/0000-0003-0893-6068
Langley, Tessa https://orcid.org/0000-0001-9560-1148
Bishop, Simon https://orcid.org/0000-0001-8527-7081
Sahota, Opinder https://orcid.org/0000-0003-0055-7637
- License Information
-
More Information
Article History
Received: 9 August 2022
Accepted: 23 May 2023
First Online: 9 June 2023
Declarations
:
: ZP reports paid non-promotional consultancy for UCB. AM, NC,AB, MN, JG, NG, JLB, TL, SB, and OS declare that they have no conflicts of interest. SD reports a grant from Roche Diagnostics to her employing institution to fund research into the cost-effectiveness of using a biomarker to monitor response to treatment with antifracture medication.
